Annual EBITDA
-$16.38 M
-$1.47 M-9.85%
December 31, 2023
Summary
- As of February 7, 2025, INDP annual EBITDA is -$16.38 million, with the most recent change of -$1.47 million (-9.85%) on December 31, 2023.
- During the last 3 years, INDP annual EBITDA has fallen by -$12.78 million (-355.12%).
- INDP annual EBITDA is now -355.12% below its all-time high of -$3.60 million, reached on December 31, 2020.
Performance
INDP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.14 M
+$966.80 K+23.53%
September 1, 2024
Summary
- As of February 7, 2025, INDP quarterly EBITDA is -$3.14 million, with the most recent change of +$966.80 thousand (+23.53%) on September 1, 2024.
- Over the past year, INDP quarterly EBITDA has increased by +$966.80 thousand (+23.53%).
- INDP quarterly EBITDA is now -494.64% below its all-time high of -$528.40 thousand, reached on June 30, 2021.
Performance
INDP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$15.37 M
+$1.11 M+6.71%
September 1, 2024
Summary
- As of February 7, 2025, INDP TTM EBITDA is -$15.37 million, with the most recent change of +$1.11 million (+6.71%) on September 1, 2024.
- Over the past year, INDP TTM EBITDA has increased by +$1.11 million (+6.71%).
- INDP TTM EBITDA is now -429.18% below its all-time high of -$2.90 million, reached on June 30, 2020.
Performance
INDP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INDP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.8% | +23.5% | +6.7% |
| 3 y3 years | -355.1% | +10.1% | +1.4% |
| 5 y5 years | -355.1% | +10.1% | +1.4% |
INDP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -111.9% | at low | at high | +29.5% | -98.9% | +6.7% |
| 5 y | 5-year | -355.1% | at low | -494.6% | +29.5% | -429.2% | +6.7% |
| alltime | all time | -355.1% | at low | -494.6% | +29.5% | -429.2% | +6.7% |
Indaptus Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.14 M(-23.5%) | -$15.37 M(-6.7%) |
| Jun 2024 | - | -$4.11 M(+4.2%) | -$16.48 M(+3.9%) |
| Mar 2024 | - | -$3.94 M(-5.7%) | -$15.86 M(-3.1%) |
| Dec 2023 | -$16.38 M(+9.8%) | -$4.18 M(-1.6%) | -$16.38 M(+0.6%) |
| Sep 2023 | - | -$4.25 M(+21.6%) | -$16.28 M(+4.5%) |
| Jun 2023 | - | -$3.49 M(-21.5%) | -$15.59 M(-2.3%) |
| Mar 2023 | - | -$4.45 M(+9.0%) | -$15.96 M(+7.1%) |
| Dec 2022 | -$14.91 M | -$4.09 M(+15.0%) | -$14.91 M(+6.2%) |
| Sep 2022 | - | -$3.55 M(-8.2%) | -$14.04 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$3.87 M(+13.7%) | -$13.86 M(+31.8%) |
| Mar 2022 | - | -$3.40 M(+5.7%) | -$10.52 M(+36.1%) |
| Dec 2021 | -$7.73 M(+114.8%) | -$3.22 M(-4.4%) | -$7.73 M(+46.4%) |
| Sep 2021 | - | -$3.37 M(+537.3%) | -$5.28 M(+52.7%) |
| Jun 2021 | - | -$528.40 K(-13.9%) | -$3.46 M(-40.7%) |
| Mar 2021 | - | -$613.80 K(-20.1%) | -$5.83 M(+11.8%) |
| Dec 2020 | -$3.60 M | - | - |
| Dec 2020 | - | -$768.30 K(-50.3%) | -$5.22 M(+17.3%) |
| Sep 2020 | - | -$1.55 M(-46.8%) | -$4.45 M(+53.2%) |
| Jun 2020 | - | -$2.90 M | -$2.90 M |
FAQ
- What is Indaptus Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Indaptus Therapeutics?
- What is Indaptus Therapeutics annual EBITDA year-on-year change?
- What is Indaptus Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Indaptus Therapeutics?
- What is Indaptus Therapeutics quarterly EBITDA year-on-year change?
- What is Indaptus Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Indaptus Therapeutics?
- What is Indaptus Therapeutics TTM EBITDA year-on-year change?
What is Indaptus Therapeutics annual EBITDA?
The current annual EBITDA of INDP is -$16.38 M
What is the all time high annual EBITDA for Indaptus Therapeutics?
Indaptus Therapeutics all-time high annual EBITDA is -$3.60 M
What is Indaptus Therapeutics annual EBITDA year-on-year change?
Over the past year, INDP annual EBITDA has changed by -$1.47 M (-9.85%)
What is Indaptus Therapeutics quarterly EBITDA?
The current quarterly EBITDA of INDP is -$3.14 M
What is the all time high quarterly EBITDA for Indaptus Therapeutics?
Indaptus Therapeutics all-time high quarterly EBITDA is -$528.40 K
What is Indaptus Therapeutics quarterly EBITDA year-on-year change?
Over the past year, INDP quarterly EBITDA has changed by +$966.80 K (+23.53%)
What is Indaptus Therapeutics TTM EBITDA?
The current TTM EBITDA of INDP is -$15.37 M
What is the all time high TTM EBITDA for Indaptus Therapeutics?
Indaptus Therapeutics all-time high TTM EBITDA is -$2.90 M
What is Indaptus Therapeutics TTM EBITDA year-on-year change?
Over the past year, INDP TTM EBITDA has changed by +$1.11 M (+6.71%)